BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15028289)

  • 21. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
    Lee J; Rhee BK; Bae GY; Han YM; Kim J
    Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic organization of the mouse Msh4 gene producing bicistronic, chimeric and antisense mRNA.
    Hirano M; Noda T
    Gene; 2004 Nov; 342(1):165-77. PubMed ID: 15527976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
    Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
    Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A functional promoter region of the CKLFSF2 gene is located in the last intron/exon region of the upstream CKLFSF1 gene.
    Xu M; Yang S; Gao Y; Shi S; Ma D
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1296-307. PubMed ID: 15778092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the human PRIP-1 gene structure and transcriptional regulation.
    Murakami A; Matsuda M; Nakasima A; Hirata M
    Gene; 2006 Nov; 382():129-39. PubMed ID: 16952428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic organization and transcriptional analysis of gonadotropin-regulated testicular RNA helicase--GRTH/DDX25 gene.
    Tsai-Morris CH; Lei S; Jiang Q; Sheng Y; Dufau ML
    Gene; 2004 Apr; 331():83-94. PubMed ID: 15094194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation.
    Pugacheva EM; Tiwari VK; Abdullaev Z; Vostrov AA; Flanagan PT; Quitschke WW; Loukinov DI; Ohlsson R; Lobanenkov VV
    Hum Mol Genet; 2005 Apr; 14(7):953-65. PubMed ID: 15731119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
    Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
    Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
    Li Y; Chen Z
    Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J; Ather JL; Sonstegard TS; Kerr DE
    Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium.
    Okada Y; Yano K; Jin E; Funahashi N; Kitayama M; Doi T; Spokes K; Beeler DL; Shih SC; Okada H; Danilov TA; Maynard E; Minami T; Oettgen P; Aird WC
    Circ Res; 2007 Jun; 100(12):1712-22. PubMed ID: 17495228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1 in a region frequently altered in human tumour cells.
    Praml C; Savelyeva L; Schwab M
    Oncogene; 2003 Jul; 22(30):4765-73. PubMed ID: 12879023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of Fshr occurs through a conserved, hypersensitive site in the first intron.
    Hermann BP; Heckert LL
    Mol Endocrinol; 2005 Aug; 19(8):2112-31. PubMed ID: 15817654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of cystathionine beta-synthase--a gene on chromosome 21.
    Kraus JP
    Prog Clin Biol Res; 1990; 360():201-14. PubMed ID: 2247508
    [No Abstract]   [Full Text] [Related]  

  • 38. YBX1 is a modulator of MIA/CD-RAP-dependent chondrogenesis.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    PLoS One; 2013; 8(12):e82166. PubMed ID: 24349210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA.
    Bosserhoff AK; Hein R; Bogdahn U; Buettner R
    J Biol Chem; 1996 Jan; 271(1):490-5. PubMed ID: 8550608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression, function and clinical relevance of MIA (melanoma inhibitory activity).
    Bosserhoff AK; Buettner R
    Histol Histopathol; 2002 Jan; 17(1):289-300. PubMed ID: 11813878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.